A privately-held medical device company developing innovative solutions addressing the $1 billion worldwide cervical spine market.
The company's focus is on commercializing the DTRAX platform of tissue-sparing cervical implants and instruments to treat cervical degenerative disc disease through indirect decompression, stabilization and fusion.
1331 N. California Blvd Suite 320
Walnut Creek, California
94596 United States